Notice Number: NOT-HL-09-124
Key Dates
Release Date: August 19, 2009
Issued by
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov/)
Purpose
The purpose of this Notice is to update NOT-HL-08-113 and advise investigators who plan to submit applications under the parent FOA (PA-09-164) for the NIH Exploratory/Developmental Research Grant (R21) award mechanism that the NHLBI does not accept the assignment of applications which focus primarily on cancer. There are some areas of overlapping interest, e.g., basic aspects of lung malignancies intersecting with the pathogenesis of various lung disorders, or the use of lung cancer therapies that may impact on other lung diseases, hematological malignancies resulting from disruptions in hematopoiesis, myeloproliferative and myelodysplastic disorders, or the use of hematopoietic stem cell transplantation and other cellular therapies. Therefore, applicants are strongly encouraged to contact the NHLBI before submitting an application in response to this FOA.Inquiries
Inquiries concerning this Notice may be directed to:
Roy White, Ph.D.
Division of Extramural Research Activities
National Heart, Lung and Blood Institute
National Institutes of Health
6701 Rockledge Drive
Room 7176, MSC 7956
Bethesda, MD 20892-7924
Telephone: (301) 435-0310
Fax: (301) 480-4755
Email: [email protected]
Antonello Punturieri, M.D., Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
6701 Rockledge Drive
Room 10146, MSC 7952
Bethesda, MD 20892-7952
Telephone: (301) 435-0230
Fax: (301) 480-5577
Email: [email protected]
Nancy Difronzo, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
National Institutes of Health
6701 Rockledge Drive
Room 9146, MSC 7950
Bethesda, MD 20892-7950
Telephone: (301) 435-0065
Fax: (301) 480-0868
Email: [email protected]
and Human Services (HHS)
